These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 8999140
1. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. Tanaka E. Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140 [No Abstract] [Full Text] [Related]
2. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. Sakatani M. Kekkaku; 1996 Sep; 71(9):544-7. PubMed ID: 8999139 [No Abstract] [Full Text] [Related]
3. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. Sato K, Ebe T. Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891 [Abstract] [Full Text] [Related]
4. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection]. Taki H, Ogawa K, Nakagawa T, Kashima K, Tarumi O, Saitou Y, Yamada N, Tano M, Nikai T. Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572 [Abstract] [Full Text] [Related]
5. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones]. Tomioka H, Sato K, Saito H. Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135 [No Abstract] [Full Text] [Related]
6. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520 [Abstract] [Full Text] [Related]
7. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study. Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H. Ann Am Thorac Soc; 2014 Jan 01; 11(1):23-9. PubMed ID: 24298907 [Abstract] [Full Text] [Related]
8. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment]. Kobashi Y, Oka M. Kekkaku; 2008 Dec 01; 83(12):779-84. PubMed ID: 19172823 [Abstract] [Full Text] [Related]
9. [A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease]. Fujiwara K. Kekkaku; 2005 Sep 01; 80(9):601-5. PubMed ID: 16245791 [Abstract] [Full Text] [Related]
10. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ. Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282 [Abstract] [Full Text] [Related]
11. [Perspective of pulmonary MAC infection treatment]. Kurashima A. Kekkaku; 2007 Mar 15; 82(3):195-9. PubMed ID: 17444124 [Abstract] [Full Text] [Related]
12. [Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. Stengel W. Dtsch Med Wochenschr; 1999 Oct 15; 124(41):1205-6. PubMed ID: 10572519 [No Abstract] [Full Text] [Related]
13. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F. Am J Respir Crit Care Med; 1999 Sep 15; 160(3):866-72. PubMed ID: 10471610 [Abstract] [Full Text] [Related]
14. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). Schouten JT, Whittemore S. STEP Perspect; 1996 Sep 15; 8(3):5-6. PubMed ID: 11364267 [Abstract] [Full Text] [Related]
16. [Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages]. Sato K, Akaki T, Tomioka H. Kekkaku; 1997 Jul 15; 72(7):449-53. PubMed ID: 9259129 [Abstract] [Full Text] [Related]
17. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112 [Abstract] [Full Text] [Related]
18. [Two cases of Mycobacterium szulgai pulmonary disease in the elderly]. Hamada M, Kajiki A, Nagata N, Wakamatsu K, Komori M, Matsunaga K, Iwata Y, Ishimatsu A, Kitahara Y. Kekkaku; 2005 May 01; 80(5):427-32. PubMed ID: 16083051 [Abstract] [Full Text] [Related]
19. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. Payen MC, De Wit S, Clumeck N. Rev Mal Respir; 1997 Dec 01; 14 Suppl 5():S142-51. PubMed ID: 9496599 [Abstract] [Full Text] [Related]
20. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R. J Infect Dis; 2000 Apr 01; 181(4):1289-97. PubMed ID: 10762562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]